Wells Fargo’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Wells Fargo’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-50	Closed	–	–	6550
2014 Q4	$0	Hold	50	–	–	﹤0.01%	6589
2014 Q3	$0	Hold	50	–	–	﹤0.01%	6505
2014 Q2	$0	Hold	50	–	–	﹤0.01%	6443
2014 Q1	$0	Hold	50	–	–	﹤0.01%	6253
2013 Q4	$0	Hold	50	–	–	﹤0.01%	6103
2013 Q3	$0	Hold	50	–	–	﹤0.01%	6000
2013 Q2	$0	Buy	+50	New	+$262	﹤0.01%	5815

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Wells Fargo's ECTE Position: Q1 2015 in Review

Wells Fargo sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q1 2015, closing a stake of 50 shares.

Wells Fargo first reported a position in ECTE in Q2 2013 and held it in 7 quarters. The position peaked at $0 in Q4 2014. 18 funds tracked by Wall St. Rank hold ECTE as of Q1 2015.

Wells Fargo reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q1 2015 after selling out during the quarter.
Wells Fargo sold 50 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q1 2015.
Wells Fargo first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 7 quarters.
Wells Fargo's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $0 in Q4 2014.
18 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q1 2015.

Based on Wells Fargo's 13F filing for Q1 2015, filed 12 May 2015.